| Clinical outcomes | Age group of STEMI patients | |||||
| Group-I n = 10 | Group-II n = 96 | Group-III n = 94 | ||||
| In-hospital outcomes | ||||||
| Death, n (%) | 0 (0%) | 2 (2.1%) | 3 (3.2%) | |||
| Repeat PCI, n (%) | 0 (0%) | 1 (1%) | 1 (1.1%) | |||
| Major bleeding, n (%) | 0 (0%) | 2 (2.1%) | 0 (0%) | |||
| Emergency CABG, n (%) | 0 (0%) | 1 (1%) | 0 (0%) | |||
| Major adverse clinical outcomes, n (%) | 0 (0%) | 6 (6.3%) | 4 (4.3%) | |||
| Outcomes at 30-day follow-up | ||||||
| Death, n (%) | 0 (0%) | 1 (1%) | 1 (1.1%) | |||
| Repeat PCI, n (%) | 0 (0%) | 1 (1%) | 2 (2.1%) | |||
| Major bleeding, n (%) | 0 (0%) | 0 (0%) | 1 (1.1%) | |||
| Emergency CABG, n (%) | 0 (0%) | 0 (0%) | 1 (1.1%) | |||
| Major adverse clinical outcomes, n (%) | 0 (0%) | 2 (2.1%) | 5 (5.3%) | |||